0001437749-16-026178.txt : 20160226 0001437749-16-026178.hdr.sgml : 20160226 20160226164347 ACCESSION NUMBER: 0001437749-16-026178 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160226 DATE AS OF CHANGE: 20160226 EFFECTIVENESS DATE: 20160226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-258212 FILM NUMBER: 161462646 BUSINESS ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 5980 HORTON STREET STREET 2: SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0707 D LIVE 0001389545 NovaBay Pharmaceuticals, Inc. 5980 HORTON STREET SUITE 550 EMERYVILLE CA CALIFORNIA 94608 (510) 899-8800 DELAWARE NovaCal Pharmaceuticals, Inc. None Corporation true Mark M. Sieczkarek 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Director Thomas J. Paulson 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Justin M. Hall 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Roy J. Wu 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Executive Officer Paul E. Freiman 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Xinzhou (Paul) Li 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Gail J. Maderis 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director T. Alex McPherson 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Massimo Radaelli 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Xiaoyan Liu 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Mijia Wu 5980 Horton Street, Suite 550 Emeryville CA CALIFORNIA 94608 Director Pharmaceuticals Decline to Disclose 06b false 2016-02-16 false true false 0 China Kington Asset Management Co. Ltd. None None None Suite 6C, Bldg 3, You You Century Plz No.428 Yang Gao, S. Rd, Pu Dong New Dist Shanghai F4 CHINA 200127 true 2830804 2830804 0 $239,489.17 of securities were offered and sold within the United States, and $2,591,314.80 of securities were offered and sold in non-U.S. jurisdictions. false 3 155479 0 No commissions were paid on sales to U.S. citizens or persons or entities domiciled within the United States. 0 false NovaBay Pharmaceuticals, Inc. /s/ Thomas J. Paulson Thomas J. Paulson Chief Financial Officer 2016-02-26